Evidence map›Paper›PMID 21874330›Full record

ArticleEuropean journal of nutrition2012

Influence of extra virgin olive oil diet enriched with hydroxytyrosol in a chronic DSS colitis model.

Susana Sánchez-Fidalgo, L Sánchez de Ibargüen, A Cárdeno, C Alarcón de la Lastra

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03408847 (Supplementation of Extra Virgin Olive Oil Monocultivar Coratina in Patients With Active Ulcerative Colitis), which is not on this map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03408847 naunknown statusnot on this mapstarted 2017, after this paper: background citation

Supplementation of Extra Virgin Olive Oil Monocultivar Coratina in Patients With Active Ulcerative Colitis

TypeinterventionalSponsorCasa Sollievo della Sofferenza IRCCSRan2017 to 2019Enrolled30ConditionsUlcerative Colitis Chronic MildArmsBeclomethasone dipropionate in addition to MC-EVOO, Beclomethasone dipropionate in addition to refined oil
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 124 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Susana Sánchez-FidalgoDepartment of Pharmacology, School of Pharmacy, University of Seville, Seville, Spain. fidalgo@us.es
L Sánchez de Ibargüen
A Cárdeno
C Alarcón de la Lastra
Universidad de Sevilla · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRecent epidemiological studies have shown that habitual consumption of extra virgin olive oil (EVOO), the characteristic culinary fat of the Mediterranean area, is effective in the prevention of diverse types of digestive disorders such as inflammatory bowel disease. Many of these benefits are, in addition to its high proportion of oleic acid, due to the high content of phenolic compounds.

methodsSix-week-old mice were randomized into three dietary groups: standard, EVOO and hydroxytyrosol-enriched EVOO. After 30 days, mice that were exposed to 3% DSS for 5 days developed acute colitis that progressed to severe chronic inflammation during a regime of 21 days of water.

resultsDiets enriched with EVOO significantly attenuated the clinical and histological signs of damage, improving results from disease activity index and reducing about 50% the mortality caused by DSS. Moreover, hydroxytyrosol supplement showed better results. Cytokines study showed that TNF-α was maintained near to sham control and IL-10 levels were significantly improved in EVOO and EVOO plus hydroxytyrosol diet-DSS groups. In the same way, COX-2 and iNOS were downregulated, and the activation of p38 MAPK was reduced. We also observed a higher significant reduction in iNOS in hydroxytyrosol-enriched EVOO compared with EVOO alone.

conclusionsEVOO diets exerted a noteworthy beneficial effect in chronic DSS-induced colitis by cytokine modulation and COX-2 and iNOS reduction via downregulation of p38 MAPK. In addition to the beneficial effect by EVOO, supplementation of the diet with hydroxytyrosol may improve chronic colitis through iNOS downregulation plus its antioxidant capacity.

Indexed as

Disease Models, AnimalFood, FortifiedAnimalsAnti-Inflammatory Agents, Non-SteroidalAntioxidantsColitis, UlcerativeColonCyclooxygenase 2CytokinesDextran SulfateDown-RegulationFemaleIntestinal MucosaMAP Kinase Signaling SystemMiceMice, Inbred C57BL3,4-dihydroxyphenylethanolAnti-Inflammatory Agents, Non-SteroidalAntioxidantsCyclooxygenase 2CytokinesDextran SulfateNitric Oxide Synthase Type IINos2 protein, mouseOlive OilPhenylethyl AlcoholPlant OilsPtgs2 protein, mouse

Identifiers

PMID21874330
OpenAlexW2033302903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.